GeneOne Life Science Inc (011000) — Cash Flow Reinvestment Rate

Latest as of December 2021: 32.88x

GeneOne Life Science Inc (011000) has a Cash Flow Reinvestment Rate of 32.88x as of December 2021, reinvesting ₩120.54 Billion (capex ₩35.40 Billion plus investments ₩-85.14 Billion) from operating cash flow of ₩3.67 Billion. Check GeneOne Life Science Inc (011000) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

32.88x

(Capex + Investments) / Operating CF

Total Reinvested

₩120.54 Billion

Capex + Investments

Operating Cash Flow

₩3.67 Billion

KRW

Capital Expenditures

₩35.40 Billion

KRW

GeneOne Life Science Inc Cash Flow Reinvestment Rate (2015–2015)

Historical reinvestment intensity for GeneOne Life Science Inc across 1 annual periods. Explore long-term investment intensity of GeneOne Life Science Inc to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for GeneOne Life Science Inc (2015–2015)

Year-by-year capital reinvestment analysis for GeneOne Life Science Inc. For live market cap and broader valuation context, see 011000 stock market capitalisation.

Year	Reinvestment Rate	Total Reinvested (KRW)	Operating CF	Capex	YoY Change
2015	3.34x	₩2.60 Billion	₩778.50 Million	₩2.04 Billion	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow